Naltrexone blocks alcohol-induced effects on kappa-opioid receptors in the plasma membrane.  Oasa S, Sezgin E, Ma Y, Horne DA, Radmilović MD, Jovanović-Talisman T, Martin-Fardon R, Vukojević V, Terenius L.  Transl Psychiatry. 2024 Nov ...

Patients with Opioid Use Disorder Choosing Treatment with Extended-Release Naltrexone: A 6-Month Naturalistic Study.  Brenna IH, Waleur KM, Benth JŠ, Solli KK, Mordal J, Løberg EM, Weimand B, Tanum L.  Eur Addict Res. 2024 Nov 4:1-12. ...

Endogenous mu-opioid modulation of social connection in humans: a systematic review and meta-analysis.  Løseth G, Trøstheim M, Leknes S.  Transl Psychiatry. 2024 Sep 17;14(1):379. doi: 10.1038/s41398-024-03088-3. PMID: 39289345; PMCID:...

Medial prefrontal neuroplasticity during extended-release naltrexone treatment of opioid use disorder - a longitudinal structural magnetic resonance imaging study.  Shi Z, Li X, Todaro DR, Cao W, Lynch KG, Detre JA, Loughead J, Langleben DD,...

Loss of Consciousness After Naltrexone Implantation: A Case Report.  Doğan O.  Turk Psikiyatri Derg. 2024 Fall;35(3):245-247. doi: 10.5080/u26711. PMID: 39224997; PMCID: PMC11375739. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1...

Safety of naltrexone in patients with cirrhosis.  Thompson R, Taddei T, Kaplan D, Rabiee A.  JHEP Rep. 2024 Apr 10;6(7):101095. doi: 10.1016/j.jhepr.2024.101095. PMID: 38961852; PMCID: PMC11220533. https://www.jhep-reports.eu/article/...